Physician profile
Ann Sheehy
NPI 1548608177
$5,998.54
in general payments reported to CMS, 2019-2025
15 companies · $2,980 in 2025
The $2,980 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $609 · 2023: $1,562 · 2024: $524 · 2025: $2,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,615 · Travel and Lodging: $2,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,615.03 |
| Travel and Lodging | $2,450.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,926.41 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Pacira Pharmaceuticals Incorporated | $833.92 | 2023 | Iovera |
| Medtronic, INC. | $583.56 | 2021-2023 | Intellis Adaptivestim |
| Abbvie INC. | $469.60 | 2022-2025 | |
| Averitas Pharma INC. | $371.55 | 2023-2025 | Qutenza |
| Abbott Laboratories | $270.79 | 2024-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $160.09 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.98 | 2024 | Caplyta |
| Grt US Holding, INC. | $108.39 | 2022 | |
| Saluda Medical Americas, INC. | $35.85 | 2025 | Evoke |
| Vertex Pharmaceuticals Incorporated | $30.36 | 2025 | |
| Globus Medical, INC. | $22.02 | 2023 | Excelsiusgps Robotic Navigation System |
| Collegium Pharmaceutical, INC. | $21.43 | 2025 | Belbuca |
| Spr Therapeutics, INC | $20.06 | 2024 | Sprint Pns System |
| Nevro Corp. | $19.53 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Sheehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.